JY
DNA icon

Jeff Yass’s Ginkgo Bioworks DNA Stock Holding History

Jeff Yass’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$390K Sell
39,372
-16,864
-30% -$141K ﹤0.01% 10473
2026
Q1 		$345K Sell
56,236
-44,760
-44% -$372K ﹤0.01% 10576
2025
Q4 		$839K Sell
100,996
-136,062
-57% -$1.47M ﹤0.01% 7570
2025
Q3 		$3.46M Buy
237,058
+50,381
+27% +$603K ﹤0.01% 4709
2025
Q2 		$2.1M Buy
186,677
+66,100
+55% +$512K ﹤0.01% 5679
2025
Q1 		$687K Sell
120,577
-12,972
-10% -$132K ﹤0.01% 8187
2024
Q4 		$1.31M Buy
133,549
+120,952
+960% +$1.04M ﹤0.01% 6302
2024
Q3 		$103K Sell
12,597
-38,425
-75% -$385K ﹤0.01% 11042
2024
Q2 		$682K Sell
51,022
-13,320
-21% -$397K ﹤0.01% 7491
2024
Q1 		$2.99M Sell
64,342
-56,925
-47% -$2.95M ﹤0.01% 4528
2023
Q4 		$8.2M Buy
121,267
+48,081
+66% +$2.94M ﹤0.01% 2915
2023
Q3 		$5.3M Buy
73,186
+1,397
+2% +$112K ﹤0.01% 3419
2023
Q2 		$5.34M Buy
71,789
+7,350
+11% +$435K ﹤0.01% 3410
2023
Q1 		$3.43M Sell
64,439
-5,438
-8% -$345K ﹤0.01% 4050
2022
Q4 		$4.72M Buy
69,877
+39,887
+133% +$3.67M ﹤0.01% 3325
2022
Q3 		$3.74M Sell
29,990
-18,240
-38% -$2.17M ﹤0.01% 3648
2022
Q2 		$4.59M Sell
48,230
-30,881
-39% -$3.77M ﹤0.01% 3324
2022
Q1 		$12.8M Buy
79,111
+66,436
+524% +$12.9M ﹤0.01% 2232
2021
Q4 		$4.21M Buy
12,675
+6,533
+106% +$3.1M ﹤0.01% 4037
2021
Q3 		$2.85M Buy
+6,142
New +$2.99M ﹤0.01% 5062

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Jeff Yass's DNA Position: Q2 2026 in Review

Jeff Yass reduced its Ginkgo Bioworks (DNA) stake by 30% in Q2 2026, selling an estimated $141K and leaving 39,372 shares worth $390K. The position accounts for ﹤0.01% of the portfolio, ranked #10473.

Jeff Yass first reported a position in DNA in Q3 2021 and has held it in 20 quarters since. The position peaked at $12.8M in Q1 2022. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Jeff Yass held 39,372 shares of Ginkgo Bioworks worth $390K as of Q2 2026.
  • Jeff Yass sold 16,864 Ginkgo Bioworks shares in Q2 2026, an estimated $141K.
  • Ginkgo Bioworks made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #10473 holding.
  • Jeff Yass first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 20 quarters since.
  • Jeff Yass's Ginkgo Bioworks position peaked at $12.8M in Q1 2022.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.